Several studies demonstrated that the transcriptional activation of SOX2 is linked with tumorigenesis that leads to various cancers including glioblastoma, small cell lung cancer (SCLC), lung squamous cell carcinoma (LSCC), lung adenocarcinoma, breast cancer, and colon cancer [83]. Here, SOX2 is linked to breast cancer.